Cargando…
New Cancer Immunotherapy Agents in Development: a report from an associated program of the 31(st)Annual Meeting of the Society for Immunotherapy of Cancer, 2016
This report is a summary of ‘New Cancer Immunotherapy Agents in Development’ program, which took place in association with the 31st Annual Meeting of the Society for Immunotherapy of Cancer (SITC), on November 9, 2016 in National Harbor, Maryland. Presenters gave brief overviews of emerging clinical...
Autores principales: | Adusumilli, Prasad S., Cha, Edward, Cornfeld, Mark, Davis, Thomas, Diab, Adi, Dubensky, Thomas W., Evans, Elizabeth, Grogan, Jane L., Irving, Bryan A., Leidner, Rom S., Olwill, Shane A., Soon-Shiong, Patrick, Triebel, Frederic, Tuck, David, Bot, Adrian, Dansey, Roger D., Drake, Charles G., Freeman, Gordon J., Ibrahim, Ramy, Patel, Salil, Chen, Daniel S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5477277/ https://www.ncbi.nlm.nih.gov/pubmed/28649381 http://dx.doi.org/10.1186/s40425-017-0253-2 |
Ejemplares similares
-
The Value of Cancer Immunotherapy Summit at the 2016 Society for Immunotherapy of Cancer 31(st) anniversary annual meeting
por: Kaufman, Howard L., et al.
Publicado: (2017) -
Cyclic dinucleotides (CDNs) reversed T cells tolerance in anti-tumor immunotherapy
por: Fu, Juan, et al.
Publicado: (2015) -
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)
por: Cohen, Ezra E. W., et al.
Publicado: (2019) -
Molecular imaging for cancer immunotherapy
por: Lim, E.A., et al.
Publicado: (2020) -
Primer on tumor immunology and cancer immunotherapy
por: Harris, Timothy J, et al.
Publicado: (2013)